John Yan

459 total citations
21 papers, 357 citations indexed

About

John Yan is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, John Yan has authored 21 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in John Yan's work include Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (2 papers). John Yan is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (2 papers). John Yan collaborates with scholars based in Brazil, Belgium and New Zealand. John Yan's co-authors include Vinayak Bhat, Ricardo A. Costa, Alexandre Abizaid, Sara Toyloy, J. Ribamar Costa, John A. Ormiston, Lynn Morrison, Stefan Verheye, Daniel Chamié and James T. Stewart and has published in prestigious journals such as Journal of the American College of Cardiology, SAE technical papers on CD-ROM/SAE technical paper series and Electrophoresis.

In The Last Decade

John Yan

19 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Yan Brazil	9	277	168	137	63	42	21	357
R Waksman United States	7	318 1.1×	189 1.1×	107 0.8×	66 1.0×	29 0.7×	16	402
P. Beerbaum Germany	7	84 0.3×	226 1.3×	83 0.6×	168 2.7×	56 1.3×	11	392
Marc Silvestri France	11	488 1.8×	368 2.2×	137 1.0×	247 3.9×	18 0.4×	26	545
S. J. Dong China	10	41 0.1×	207 1.2×	71 0.5×	73 1.2×	115 2.7×	15	523
P. V. Satyanarayana India	4	99 0.4×	239 1.4×	18 0.1×	35 0.6×	89 2.1×	9	478
H. Sugimoto United States	7	137 0.5×	291 1.7×	169 1.2×	13 0.2×	3 0.1×	11	391
M. Deiwick Germany	11	173 0.6×	218 1.3×	52 0.4×	23 0.4×	7 0.2×	23	364
Claus Harder Germany	9	237 0.9×	84 0.5×	75 0.5×	15 0.2×	216 5.1×	15	542
Maximilian Kütting Germany	8	79 0.3×	213 1.3×	59 0.4×	39 0.6×	7 0.2×	18	278

Countries citing papers authored by John Yan

Since Specialization

Citations

This map shows the geographic impact of John Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Yan more than expected).

Fields of papers citing papers by John Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Yan. The network helps show where John Yan may publish in the future.

Co-authorship network of co-authors of John Yan

This figure shows the co-authorship network connecting the top 25 collaborators of John Yan. A scholar is included among the top collaborators of John Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Yan. John Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yan, John, M Bakri Hammami, Nishi Shah, et al.. (2024). Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database. Annals of Hematology. 103(9). 3543–3551.

Yan, John, et al.. (2024). Testosterone therapy as a novel approach to the management of cytopenias in myelodysplastic neoplasms: a review of literature and case report. Journal of Cancer Research and Clinical Oncology. 150(8).

Niñonuevo, Milady R., et al.. (2022). Rapid multi‐attribute characterization of intact bispecific antibodies by a microfluidic chip‐based integrated icIEF‐MS technology. Electrophoresis. 44(3-4). 378–386. 14 indexed citations

Yan, John, Gang Li, & Kan Liu. (2020). Development Trend of Wind Power Technology. Maryland Shared Open Access Repository (USMAI Consortium). 7(6). 3 indexed citations

Yan, John, Gang Li, & Kan Liu. (2020). Development Trend of Wind Power Technology. International Journal of Advanced Engineering Research and Science. 7(6). 124–132. 8 indexed citations

Verheye, Stefan, Michael Mæng, Carsten Skurk, et al.. (2017). TCT-16 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 5-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 70(18). B7–B8. 1 indexed citations

Verheye, Stefan, Lynn Morrison, Michael Mæng, et al.. (2016). TCT-32 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 4-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 68(18). B13–B13. 4 indexed citations

Abizaid, Alexandre, Ricardo A. Costa, Joachim Schöfer, et al.. (2016). Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions. JACC: Cardiovascular Interventions. 9(6). 565–574. 88 indexed citations

Verheye, Stefan, Joachim Schöfer, Michael Mæng, et al.. (2015). TCT-17 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results. Journal of the American College of Cardiology. 66(15). B7–B7. 1 indexed citations

10.

Abizaid, Alexandre, Michael Mæng, Bernhard Witzenbichler, et al.. (2014). TCT- 610 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 2-Year Clinical Results. Journal of the American College of Cardiology. 64(11). B178–B178. 8 indexed citations

11.

Verheye, Stefan, Mark Webster, Jim Stewart, et al.. (2013). CRT-4 Multi-center, First-in-man Evaluation Of The Myolimus-eluting Bioresorbable Coronary Scaffold: 6-month Clinical And Imaging Results. JACC: Cardiovascular Interventions. 6(2). S2–S2. 1 indexed citations

12.

Abizaid, Alexandre, Michael Mæng, Bernhard Witzenbichler, et al.. (2013). TCT-37 Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes. Journal of the American College of Cardiology. 62(18). B13–B13. 3 indexed citations

13.

Costa, Ricardo A., Stefan Verheye, J. Ribamar Costa, et al.. (2013). TCT-419 Side branch patency after implantation of the novel DESolve bioresorbable vascular scaffold system in the treatment of de novo coronary lesions. Journal of the American College of Cardiology. 62(18). B130–B130. 1 indexed citations

14.

Verheye, Stefan, John A. Ormiston, James T. Stewart, et al.. (2013). A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation. JACC: Cardiovascular Interventions. 7(1). 89–99. 129 indexed citations

15.

Costa, J. Ribamar, John A. Ormiston, Alexandre Abizaid, et al.. (2012). TCT-298 Six-month Intravascular Ultrasound Analysis of the DESolve FIM Trial with a Novel PLLA-based Fully Biodegradable Drug-eluting Scaffold. Journal of the American College of Cardiology. 60(17). B85–B85. 3 indexed citations

16.

Verheye, Stefan, Mark Webster, James T. Stewart, et al.. (2012). TCT-563 Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results. Journal of the American College of Cardiology. 60(17). B163–B163. 8 indexed citations

17.

Yan, John & Vinayak Bhat. (2009). Elixir Medical’s bioresorbable drug eluting stent (BDES) programme: an overview. EuroIntervention. 5(F). F80–F82. 11 indexed citations

18.

Abizaid, Alexandre, Fausto Feres, Ricardo A. Costa, et al.. (2008). EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions. EuroIntervention. 4(1). 53–58. 27 indexed citations

19.

Reuter, Johannes, et al.. (2006). Advanced NOx Aftertreatment System And Controls For On-Highway Heavy Duty Diesel Engines. SAE technical papers on CD-ROM/SAE technical paper series. 1. 30 indexed citations

20.

Vermund, Sten H., et al.. (1988). ASYMPTOMATIC CRYPTOSPORIDIOSIS IN A NEW YORK CITY DAY CARE CENTER. The Pediatric Infectious Disease Journal. 7(11). 806–806. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact